James Anderson stars for Lancashire in first T20 appearance for 11 years
James Anderson took three wickets in his first T20 match for 11 years as Lancashire beat Durham at Chester-le-Street to claim a third consecutive Vitality Blast North Group win.
The 42-year-old former England seamer had not played a sprint-format match since the Red Rose faced Warwickshire at Edgbaston in August 2014.
But, having retired from international duty, Anderson returned with a bang by returning figures of three for 17 from four overs to help Lancashire limit the hosts to 150 for six.
Michael Jones hit 55 before Jack Blatherwick's single from the final delivery then took Lancashire home by four wickets.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
42 minutes ago
- New York Times
Can Matheus Cunha and Liam Delap signings boost Chelsea, Manchester United's top four odds?
For more stories like this, click here to follow The Athletic's sports betting section and have them added to your feed. Legendary American basketball coach John Wooden once said, 'Never mistake activity for achievement.' Wooden spent his time coaching players who dribbled with their hands instead of their feet in the 1970s. That means it's unlikely his famous quote was directed at the transfer strategies of Manchester United and Chelsea. Advertisement In acquiring Matheus Cunha and Liam Delap, each club appears to be doing something. Whether early transfer window activity indicates edging closer to securing silverware or a place in the top four next year is another story. At the very least, it represents hope around the Blues' 2/1 and their Manchester counterparts' 5/1 top four odds. Delap and Cunha also share another similarity; their numbers don't tell the whole story of their value to each club. Let's dive deeper into the metrics. Let's not beat around the bush: Ipswich Town were objectively bad this past season. The Tractor Boys' minus-1.01 expected goal (xG) differential per 90 minutes ranked 17th in the league — nearly triple the difference of Wolves in 16th. When attackers like Delap play substantial minutes for a side this dreadful, it raises questions whether their statistics accurately reflect their abilities. At 22 years old, Delap is just about to enter his prime. Considering that context, however, his underlying numbers are, well, not great: Chelsea's incumbent striker, Nicolas Jackson, has his weaknesses, particularly around his finishing, but there's no denying his surface numbers supercede Delap. Jackson's 0.50 non-penalty xG per 90 mark is nearly double Delap's 0.27. While some forwards could make up for that gap with their contributions to build-up play or chance-creation in the final third, the former Tractor Boy doesn't do either of those things. The only thing Delap does better than Jackson is dribble past opposing defenders. For Delap's inclusion to make a significant shift in Chelsea's prospects, his underwhelming numbers have to be a by-product of Ipswich's shortcomings. The Tractor Boys only averaged 40 per cent possession during the 2024-25 season. Kieran McKenna's side also were last in touches and passes into the penalty area. Projecting what this signing means for the South Londoners means trying to determine whether Delap's numbers were underwhelming due to his own poor performance or because his team simply never had possession of the ball. Advertisement Even if the answer lies somewhere in the middle, it's hard to project Delap as the type of player that adds a ton of value to Chelsea's 22/1 title odds. The Blues' top four odds might be a different story. If Delap can prove to be an effective rotation player, then the 2/1 odds for the team to qualify for the Champions League next season seem like the better bet. Delap's numbers call into question his actual level of impact, but it's quite clear the kind of player Cunha is. The 26-year-old is a good, not great, winger whose market value rose thanks to a season buoyed by a fiery finishing streak. The Brazilian scored 15 goals off just 8.6 xG — a conversion rate that even Lionel Messi would be envious of. If the predictive strength of xG has taught us anything, it's that Cunha is headed toward a serious regression next season. Thankfully for United, he does bring a decent dose of playmaking. Cunha ranks in the 80th percentile of all attacking midfielders in expected assists and led Wolves in shot-creating actions last season. Yet even with that all-around production, there's no denying that his signing is simply a signing for the sake of change given the presence of Marcus Rashford and Alejandro Garnacho. Rashford almost exactly matches Cunha's production, while the 20-year-old Garnacho offers far more promise. Despite being six years his junior, the young Argentine matched Cunha's non-penalty xG of 0.30 this past season. The problem for United is that Garnacho and Rashford have had a series of run-ins with recent managers. Erik ten Hag and Ruben Amorim sought to find alternatives, and now the latter seems poised to push both players out of the club. At 8/15 odds to head to Barcelona, Rashford seems destined to leave Old Trafford. Garnacho's most likely destination is also outside of Manchester as Napoli (6/4) are currently the club favoured to secure his services. Advertisement As great as data is, it can't really measure the impact of someone like Cunha slotting into a starting XI match after match without high-profile spats with his manager. Professionalism and locker room cohesion may not matter as much as actually putting the ball in the back of the net, but those intangibles do matter. That said, United finished 12th in non-penalty xG differential last season. This was not an unlucky side needing some stability, it is a side in need of players who move the needle (Bruno Fernandes staying should also help). Cunha is a solid player and perhaps a better fit with Amorim, but those intangible factors aren't enough to make United's 5/1 top four odds any more enticing than they already are. Betting/Odds links in this article are provided by partners of The Athletic. Restrictions may apply. The Athletic maintains full editorial independence. Partners have no control over or input into the reporting or editing process and do not review stories before publication. (Photo of Matheus Cunha: David Rogers / Getty Images)
Associated Press
an hour ago
- Associated Press
National MPS Society Welcomes Sharon King as Chief Operating Officer (COO)
'We are honored to welcome Sharon King as our new Chief Operating Officer. Sharon brings unmatched experience, heartfelt purpose, and a legacy of advocacy that resonates deeply with our mission.'— Terri Klein DURHAM, NC, UNITED STATES, June 3, 2025 / / -- The National MPS Society is delighted to announce that Sharon King has joined the team as our inaugural Chief Operating Officer (COO). Sharon comes to us with over two decades of experience spanning rare disease nonprofits, industry, and patient advocacy. She is a passionate leader who has dedicated her life to serving patient communities and driving meaningful change in the field of rare diseases. Terri L. Klein, President and CEO at the National MPS Society, shared, 'We are honored to welcome Sharon King as our new Chief Operating Officer. Sharon brings unmatched experience, heartfelt purpose, and a legacy of advocacy that resonates deeply with our mission. Her leadership is shaped by her lived experience and a deep understanding of the challenges faced by families with rare diseases. Her ability to lead with both strategy and compassion will strengthen every facet of our work. I am confident that Sharon will help the Society reach new heights as we continue to serve and support our families. We are thrilled to welcome her and look forward to the strength she will bring to the Society.' Sharon is a longtime patient advocate and thought leader in rare disease, known for her ability to unite public officials, researchers, biotech representatives, industry leaders, and other advocates in the pursuit of rare disease treatment development and impactful public policies. Her journey in advocacy began with the founding of Taylor's Tale, an organization she co-founded in honor of her late daughter, Taylor, to raise awareness and funding for CLN1 disease (a form of Batten Disease) research. Under her leadership, Taylor's Tale grew from a grassroots initiative into a force in the fight against rare diseases. Beyond her work with Taylor's Tale, Sharon has served in key roles that reflect her dedication to improving the lives of rare disease patients and caregivers. As Senior Lead of Advocacy at Aldevron, she worked to educate, connect, and improve understanding across the stakeholder community contributing to groundbreaking advancements. Sharon is a state-appointed member of the N.C Advisory Council on Rare Diseases. The law that established the Council—the nation's first—is named for her daughter. She is also a former member of the ASGCT Patient Education committee and serves on the Emily Whitehead Foundation Board of Directors. Her work reflects her deep understanding of the unique challenges faced by rare disease patients and their caregivers, as well as her unwavering commitment to promoting patient-centered, integrated care networks. Her efforts are grounded in personal experience and driven by a vision of improving lives through collaboration, education, and innovation. As Chief Operating Officer, Sharon King brings a powerful combination of strategic leadership, lived experience, and deep compassion to the National MPS Society. Her expertise will be instrumental in advancing our mission to support individuals and families affected by MPS and ML. With her unwavering commitment to advocacy and innovation, Sharon will help guide our efforts to expand critical services, drive research, and strengthen the communities we serve. This strategic appointment comes at a pivotal moment as the Society works to close the treatment gap for all families impacted by MPS and ML. With Sharon in this vital role, our team is better positioned to move forward with intention—developing new resources, enhancing care pathways, and ensuring families are never alone in their journey from diagnosis to treatment and beyond. The National MPS Society remains a steadfast partner for the road ahead. Together, we will work toward a brighter future for those we serve. Terri Klein National MPS Society +1 919-806-0101 email us here Visit us on social media: LinkedIn Instagram Facebook YouTube Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Wall Street Journal
an hour ago
- Wall Street Journal
Ian McShane Discovered His Dark Side by Watching Westerns and Thrillers as a Kid
Ian McShane, 82, is an English actor best known for his role in HBO's 'Deadwood' series and in the 'John Wick' film franchise. The latest 'Wick' installment, 'Ballerina,' is due June 6, and he stars in the Prime Video film 'Deep Cover,' out June 12. He spoke with Marc Myers. My dad, Harry, was my hero. For much of my childhood, he played professional football for England's Manchester United. As an only child, I had him all to myself.
